Abnormal FGF signaling is often implicated in cancer. Overexpression or mutations in FGFs or their receptors can lead to uncontrolled cell proliferation and survival, contributing to tumor growth and resistance to therapy. For example, alterations in FGF receptor genes are found in various cancers, including breast, bladder, and lung cancers.
